DeepGreenX Group Inc. (“DeepGreenX,” “DXG,” or the “Company”), an AI-enabled green energy and technology company, and Sente Ventures (“Sente”), today announced a framework agreement for creating a five-year $25 billion strategic investment program (the “Program”) for companies providing solutions for clean energy generation, virtual grids, battery storage, microreactor power, and data center infrastructure, and enabling technologies to support data centers and computing hubs.

TOKYU KABUKICHO TOWER (hereinafter referred to as the "facility"), operated by TST Entertainment Inc. (Shinjuku-ku, Tokyo; President and CEO: Koichi Honda), provides entertainment content that can be enjoyed by a wide range of customers from both Japan and abroad, with the aim of transforming Kabukicho into a "global entertainment city."

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109016504/en/

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter “Meiji”) announced that the company has concluded an investment agreement with MPM BioImpact LLC, a Boston-based biotech investment firm (hereafter “MPM BioImpact”). Meiji has committed to invest USD 20 million in MPM BioImpact’s new technologies and virology strategy as a strategic partner and aims to broaden Meiji’s perspective on early-stage opportunities and enhance its global network.